Evidence mapPaperPMID 41102463Full record

ReviewNature reviews. Nephrology2026

Global landscape of kidney health across Indigenous populations.

Somkanya Tungsanga, Ikechi G Okpechi, Maria Eugenia V Bianchi, Swasti Chaturvedi, David Collister, Harley Crowshoe, Giselle M Rodriguez de Sosa, Habibu A Galadanci, Erin Hedin, Kwaifa S Ibrahim and 17 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Somkanya TungsangaDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.ORCID http://orcid.org/0000-0002-2640-1131
Ikechi G OkpechiDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.ORCID http://orcid.org/0000-0002-6545-9715
Maria Eugenia V BianchiArgentine Northeast Kidney Foundation, Resistencia, Argentina.ORCID http://orcid.org/0000-0002-2594-8602
Swasti ChaturvediDepartment of Nephrology, Sydney Children's Hospital, Sydney, New South Wales, Australia.
David CollisterDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Harley CrowshoeIndigenous Health Program, Alberta Health Services, Edmonton, Alberta, Canada.
Giselle M Rodriguez de SosaDepartment of Internal Medicine, University of New Mexico, Albuquerque, NM, USA.ORCID http://orcid.org/0000-0002-7167-2619
Habibu A GaladanciDepartment of Medicine, National Hospital, Abuja, Nigeria.
Erin HedinDivision of Nephrology, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
Kwaifa S IbrahimNephrology Unit, Department of Medicine, Wuse District Hospital, Abuja, Nigeria.
Arsh K JainDivision of Nephrology, Department of Medicine, Western University, London, Ontario, Canada.
Irene L NoronhaRenal Division, University of São Paulo Medical School, São Paulo, Brazil.
Robin L EricksonPaediatric Kidney Service, Starship Children's Hospital, University of Auckland, Auckland, New Zealand.
Jaquelyne T HughesRural and Remote Health, College of Medicine and Public Health, Flinders University, Nhulunbuy, Northern Territory, Australia.ORCID http://orcid.org/0000-0002-1867-4156
Paul KomendaDepartment of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Win KulvichitDivision of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.ORCID http://orcid.org/0000-0002-4479-125X
Roberto Pecoits-FilhoSchool of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Paraná, Brazil.
Kalani L RaphaelMedicine Section, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT, USA.
Vallabh O ShahDepartment of Internal Medicine, School of Medicine, University of New Mexico, Albuquerque, NM, USA.ORCID http://orcid.org/0000-0002-3584-4057
Malama Tafuna'iNational Kidney Foundation of Samoa, Apia, Samoa.
Caroline TaitFaculty of Social Work, University of Calgary, Calgary, Alberta, Canada.
Catherine TurnerCanadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD), Vancouver, Canada.
Curtis WalkerDepartment of Medicine, Midcentral District Health Board, Palmerston North, New Zealand.
Robert WalkerDunedin School of Medicine, University of Otago, Dunedin, New Zealand.ORCID http://orcid.org/0000-0003-3366-0956
Cathy WoodsCanadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD), Vancouver, Canada.
Adeera LevinDivision of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.ORCID http://orcid.org/0000-0003-2438-8401
Aminu K BelloDivision of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. aminu1@ualberta.ca.ORCID http://orcid.org/0000-0002-6905-5937

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 480 million individuals worldwide (~6% of the global population) are Indigenous peoples. Despite their diverse cultures and histories, the shared legacy of colonialism has profoundly shaped their health and socioeconomic status. This legacy is deeply intertwined with poverty, systemic racism and historical trauma, contributing to significant health disparities compared with non-Indigenous populations. Among the many chronic diseases disproportionately affecting Indigenous peoples, chronic kidney disease (CKD) stands out as a major public health concern. Indigenous peoples experience higher rates of CKD, yet they often face barriers to accessing responsive and culturally safe health-care services. Factors such as geographic isolation, socioeconomic disadvantages and systemic discrimination limit their access to preventive care, early disease detection and kidney replacement therapy, leading to worse health outcomes and higher mortality rates. Exposure to environmental and occupational risks and inadequate infrastructure further exacerbate CKD risk for Indigenous peoples. Here, we examine determinants of kidney disease and health among major Indigenous populations in Africa, Asia, Australia, Canada, Latin America, Aotearoa-New Zealand, the Pacific Islands and the USA. We discuss culturally safe and responsive strategies that can improve the delivery of kidney care and make policy recommendations for multiple levels of government to ensure health-care systems are equipped to meet the needs of Indigenous communities. By addressing these gaps and promoting cultural competence in kidney care, health-care providers can have a crucial role in reducing health disparities and improving Indigenous peoples' kidney health worldwide.

Indexed as

Global HealthRenal Insufficiency, ChronicHealthcare DisparitiesHealth Services AccessibilityHealth Status DisparitiesHumansIndigenous Peoples

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.